China’s Cancer Screening Pioneer New Horizon Health Raises HK$2.42 Billion in Hong Kong IPO Debut

(Source: New Horizon Health)

On Feb. 18, biotechnology company New Horizon Health (6606.HK) raised HK$2.42 billion in an initial public offering (IPO) in Hong Kong, with the firm’s IPO being oversubscribed 4133 times. The company’s 76.598 million shares were priced at HK$26.6 and quickly skyrocketed by 185% in value. The firm’s market value reached HK$30…